Teacure, from digestive diseases to diabetes and obesity… Presenting a new concept of laser treatment
Published date: 2024-11-26 09:00 Updated: 2024-11-26 08:45
Tcure, a company selected for the Gyeongnam Creative Economy Innovation Center Startup Leap Package, announced that it will enter the global market within three years with a laser-based omnidirectional light irradiation catheter fusion endoscopic treatment system.
Laser-based medical diagnosis and treatment is a rapidly developing field and is considered a key technology for future medical innovation. In the diagnostic field, lasers are used for retinal examination, precision ophthalmology diagnosis, endoscopic microscopy, blood flow examination, and cancer diagnosis. In the treatment field, skin care procedures are representative, but the scope of use is expanding to include vision correction surgery, varicose vein surgery, and targeted cancer removal surgery.
Tcure’s omnidirectional light irradiation catheter fusion endoscopic treatment system is characterized by being able to irradiate uniformly at 360 degrees, beyond the limitations of existing optical fiber-based medical lasers that only irradiate in a straight line. The company explains that this can help improve the symptoms of reflux esophagitis patients suffering from stress and eating problems.
Ticure’s laser-based omnidirectional light irradiation catheter fusion endoscopic treatment system.
Reflux esophagitis is a disease that occurs when the function of the lower esophageal sphincter, a muscle located in the lower part of the esophagus, that is, the part connected to the stomach, decreases. Currently, most patients with reflux esophagitis rely on lifestyle improvements and drug treatment.
Tcure’s solution helps improve symptoms of reflux esophagitis by irradiating a laser to the weakened lower esophageal sphincter and activating collagen regeneration in the muscle. The concept of skin beauty laser treatment to create elastic skin is applied to the inside of the esophagus.
Some medical devices for surgical treatment, such as excising part of the sphincter area or sewing with a needle, are available mainly from overseas companies, but the difficulty of the procedure is known to be high. Since Tcure’s solution can be applied to an endoscope, it is expected to greatly lower the entry barrier to surgical treatment of reflux esophagitis as the doctor can perform the procedure while directly viewing the treatment area.
T-Cure further predicts intractable diseases of various organs, such as type 2 diabetes, obesity, and high blood pressure. In the case of diabetes, the duodenum, which absorbs nutrients from our body, has a significant impact on blood sugar control. In most diabetic patients, thickening of the mucous membrane in the duodenum is observed due to excessive absorption of nutrients.
In the case of reflux esophagitis, the laser was used to regenerate the skin, but this time, the laser is used to remove the mucous membrane in the duodenum, just like removing freckles in a skin care procedure. Tcure’s solution for diabetes treatment is currently undergoing clinical trials at Asan Hospital and Severance Hospital, and overseas are already showing interest in investing.
The target market was also set overseas rather than domestically. The strategy is that if a firm presence is revealed in the global medical device market, which is mainly led by American companies, the domestic market will naturally follow the trend. Due to the nature of the medical device market, long-term clinical trials are essential and the threshold for required certification is high, but it is expected that there will be a big impact in the market as soon as the first product, which is scheduled for release in 2027, is released.
Based on this growth outlook, Tcure was selected for the ‘Deep Tech Tips’ private investment-led technology startup support program of the Ministry of SMEs and Startups. As a start-up company founded by National Pukyong National University teachers, it recently won the Gyeongnam Province Governor’s Award, the Grand Prize, at the ‘2024 Startup Leap Package GO-SPACE IR Competition’ held by the Gyeongnam Creative Economy Innovation Center.
Tcure CEO Kang Hyun-wook (third from the left) won the grand prize at the ‘2024 Startup Leap Package GO-SPACE IR Competition’ hosted by the Gyeongnam Creative Economy Innovation Center.
Tcure CEO Kang Hyun-wook said, “As we have had the overseas market in mind since our founding in 2020, we will meet the support and expectations we have received so far and three years from now we will be proudly competing with global medical device companies,” adding, “We will be confidently competing with global medical device companies in three years. “We will become a company that provides innovative endoscopic treatment solutions that maximize patients’ treatment experience,” he said.
※This article was written with the support of the Gyeongnam Creative Economy Innovation Center.
Busan = Reporter Rodong-gyun [email protected]
<img class="ximage_class" src="https://jenniferlarsenphoto.com/wp-content/uploads/sites/6293/2020/03/rockleigh-wedding-nj-southern-california-wedding-photographer-photo_0016.jpg" alt="detail photograph”>
**How does Tcure’s omnidirectional laser technology address the limitations of traditional reflux esophagitis treatments, and what are the potential benefits for patients in terms of efficacy and recovery time?**
## World Today News – Exclusive Interview: Unveiling the Future of Laser Treatment
oday we are speaking with two esteemed guests to dissect the groundbreaking innovations emerging from Tcure, a company poised to revolutionize medical treatments with its cutting-edge laser technology.
Joining us are:
**Dr. Lee Su-jin:** A leading Gastroenterologist specializing in reflux esophagitis and endoscopic treatments.
**Mr. Kim Tae-joon:** A healthcare industry analyst with expertise in medical device innovations and market trends.
Welcome to both of you.
**Dr. Lee, Tcure is focusing on utilizing omnidirectional laser light irradiation for treating reflux esophagitis. How significant is this approach compared to traditional methods?**
*(Dr. Lee answers, elaborating on the limitations of existing treatments and the potential benefits of Tcure’s technology in terms of efficacy and patient experience. She can discuss the impact of collagen regeneration and the advantages of endoscopic application.)*
**Mr. Kim, the article mentions Tcure aiming for a global expansion within three years. What are the challenges and opportunities they might face in penetrating the international market for medical devices?**
**(Mr. Kim discusses the competitive landscape of the global medical device market, highlighting the regulatory hurdles, clinical trial requirements, and investment landscape. He can also explore Tcure’s competitive advantage and potential strategies for success.)*
**The article also touches upon Tcure’s future applications in treating diabetes and obesity. Dr. Lee, is there scientific basis for using laser technology in these areas? What potential benefits and concerns exist?**
**(Dr. Lee explains the connection between diabetes, obesity and the duodenum, elaborating on the underlying mechanisms that Tcure intends to target. She can also address the ethical considerations and potential side effects associated with applying laser treatment to internal organs.) *
**Mr. Kim, investors are showing interest in Tcure’s diabetes treatment solution. What are the key factors that attract investment in such innovative medical technologies? Is there a recognizable pattern in investment trends for these types of treatments?**
*(Mr. Kim analyzes the factors driving investments in diabetes treatment innovation. He can elaborate on the market size, unmet needs, and the potential return on investment. He can also discuss the role of government support and private investment in fostering such groundbreaking research.) *
**looking towards the future, what are the long-term implications of Tcure’s technology for the medical field? How might it reshape patient care and medical practices? **
*(Both Dr. Lee and Mr. Kim offer their perspectives on the future impact of Tcure’s technology. They can discuss the potential for personalized medicine, improved treatment outcomes, and the evolution of medical technology.)*
**Thank you both for sharing your insights into this truly fascinating development in medical science. We look forward to witnessing the advancements of Tcure as it transforms the landscape of healthcare.**
